Home › NDC Lookup › RxCUI directory › RxCUI 1797843

Ciclesonide 0.05 MG/ACTUAT Metered Dose Nasal Spray [Omnaris] — RxCUI 1797843

RxNorm drug concept · Semantic branded drug
RxCUI 1797843 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1797843
Official nameCiclesonide 0.05 MG/ACTUAT Metered Dose Nasal Spray [Omnaris]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asomnaris 50 MCG/ACTUAT Metered Dose Nasal Spray; Omnaris 0.05 MG/ACTUAT Metered Dose Nasal Spray
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)3,748 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ciclesonide Nasal Spray: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a nasal steroid spray used to relieve the stuffy, runny, itchy nose and sneezing that come with allergies. Omnaris Nasal Spray is approved for seasonal allergic rhinitis — lik...
  • What is ciclesonide nasal spray actually used for?
  • Yes, you do need to prime it before the first use. Gently shake the bottle, then spray it into the air 8 times until you see a fine mist. After that, use 2 sprays in each nostril o...
  • How do I use it correctly — and do I need to prime it first?
📖 Read our full Ciclesonide Nasal Spray guide →

🕸️ Concept Web — How Ciclesonide 0.05 MG/ACTUAT Metered Dose Nasal Sp... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ciclesonide 0.05 MG/ACTUAT Metered Dose Nasal Spray [Omnaris] RxCUI 1797843

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ciclesonide 274964
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Omnaris 683073
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ciclesonide Metered Dose Nasal Spray 1797837
    • Ciclesonide Inhalant Product 1163128
    • Ciclesonide Nasal Product 1801235
    • Ciclesonide Metered Dose Nasal Spray [Omnaris] 1797842
    • Omnaris Inhalant Product 1181169
    • Omnaris Nasal Product 1801238
    • Metered Dose Nasal Spray 1797831
    • Inhalant Product 1151123
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Ciclesonide 0.05 MG/ACTUAT [Omnaris] SBDC · 790274
  • Ciclesonide Metered Dose Nasal Spray [Omnaris] SBDF · 1797842
  • Omnaris Inhalant Product SBDG · 1181169
  • Omnaris Nasal Product SBDG · 1801238
  • Omnaris BN · 683073

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1797843 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70515-0701-01 1 POUCH in 1 CARTON (70515-701-01) / 1 BOTTLE, GLASS in 1 P... Omnaris Covis Pharma US, Inc 2018-04-23
Observed labelers: Covis Pharma US, Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$22.5584
Range $22.5584–$22.5584 · middle 50% $22.5584–$22.5584 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.